While studies are currently exploring the possibilities of preventing these side effects, there are currently no GLP-1 drugs on the market that do not have the potential to cause these side effects
Not scare tactics
For example, separate publications in JCEM and JCEM Case Reports indicate that osilodrostat, an 11-hydroxylase (CYP11B1) inhibitor approved for treating Cushing syndrome, has the potential to cause prolonged adrenal insufficiency and adrenal gland shrinkage
We have used everything to treat rosacea from conventional antibiotics, to the most advanced and expensive medical lasers, to natural rosacea remedies such as exotic herbal and essential oils, to the simplest and most fundamental of all medical treatments, hyperbaric oxygen therapy and ozone therapy
M.BrannD
Retrieved from Carretero-Krug, A., Montero-Bravo, A., Morais-Moreno, C., et al